APA (7th ed.) Citation

Burlina, A. P., Ferrari, V., Divry, P., Gradowska, W., Jakobs, C., Bennett, M. J., . . . Burlina, A. B. (1999). N-acetylaspartylglutamate in Canavan disease: An adverse effector? European Journal of Pediatrics, 158(5), 406. https://doi.org/10.1007/s004310051102

Chicago Style (17th ed.) Citation

Burlina, A. P., V. Ferrari, P. Divry, W. Gradowska, C. Jakobs, M. J. Bennett, A. C. Sewell, C. Dionisi-Vici, and A. B. Burlina. "N-acetylaspartylglutamate in Canavan Disease: An Adverse Effector?" European Journal of Pediatrics 158, no. 5 (1999): 406. https://doi.org/10.1007/s004310051102.

MLA (9th ed.) Citation

Burlina, A. P., et al. "N-acetylaspartylglutamate in Canavan Disease: An Adverse Effector?" European Journal of Pediatrics, vol. 158, no. 5, 1999, p. 406, https://doi.org/10.1007/s004310051102.